Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prashant Bavi

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
The American Journal of Pathology|April 26, 2011
Bortezomib stabilizes mitotic cyclins and prevents cell cycle progression via inhibition of UBE2C in colorectal carcinomaPrashant Bavi, Shahab Uddin, Maqbool Ahmed, et al.
Journal of Clinical Pathology|August 3, 2006
HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancerKhawla Al-Kuraya, Hedvika Novotny, Prashant Bavi, et al.
Journal of Clinical Pathology|September 29, 2021
Molecular characterisation of pancreatic ductal adenocarcinoma with <i>NTRK</i> fusions and review of the literatureMichael J Allen, Amy Zhang, Prashant Bavi, et al.
American Journal of Human Genetics|November 26, 2008
Mutations in C2orf37, encoding a nucleolar protein, cause hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndromeAnas M Alazami, Amr Al-Saif, Abdulaziz Al-Semari, et al.
Cell|October 13, 2021
Spatially confined sub-tumor microenvironments in pancreatic cancerBarbara T Grünwald, Antoine Devisme, Geoffroy Andrieux, et al.
JAMA Oncology|October 22, 2016
Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal AdenocarcinomaAshton A Connor, Robert E Denroche, Gun Ho Jang, et al.
Cancer Cell|January 29, 2019
Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in MetastasesAshton A Connor, Robert E Denroche, Gun Ho Jang, et al.
Cancers|January 21, 2023
Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon CancerBernhard Mlecnik, Alessandro Lugli, Gabriela Bindea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2020
Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon CancerBernhard Mlecnik, Carlo Bifulco, Gabriela Bindea, et al.
Cancers|September 23, 2022
Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC StudyBernhard Mlecnik, Toshihiko Torigoe, Gabriela Bindea, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
The American Journal of Pathology|April 26, 2011
Bortezomib stabilizes mitotic cyclins and prevents cell cycle progression via inhibition of UBE2C in colorectal carcinomaPrashant Bavi, Shahab Uddin, Maqbool Ahmed, et al.
Journal of Clinical Pathology|August 3, 2006
HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancerKhawla Al-Kuraya, Hedvika Novotny, Prashant Bavi, et al.
Journal of Clinical Pathology|September 29, 2021
Molecular characterisation of pancreatic ductal adenocarcinoma with <i>NTRK</i> fusions and review of the literatureMichael J Allen, Amy Zhang, Prashant Bavi, et al.
American Journal of Human Genetics|November 26, 2008
Mutations in C2orf37, encoding a nucleolar protein, cause hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndromeAnas M Alazami, Amr Al-Saif, Abdulaziz Al-Semari, et al.
Cell|October 13, 2021
Spatially confined sub-tumor microenvironments in pancreatic cancerBarbara T Grünwald, Antoine Devisme, Geoffroy Andrieux, et al.
JAMA Oncology|October 22, 2016
Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal AdenocarcinomaAshton A Connor, Robert E Denroche, Gun Ho Jang, et al.
Cancer Cell|January 29, 2019
Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in MetastasesAshton A Connor, Robert E Denroche, Gun Ho Jang, et al.
Cancers|January 21, 2023
Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon CancerBernhard Mlecnik, Alessandro Lugli, Gabriela Bindea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2020
Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon CancerBernhard Mlecnik, Carlo Bifulco, Gabriela Bindea, et al.
Cancers|September 23, 2022
Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC StudyBernhard Mlecnik, Toshihiko Torigoe, Gabriela Bindea, et al.
Pageof 7